Dr Dario Neri

Sun Pharma, Philogen in agreement to commercialise NIDLEGY in Europe, Australia, New Zealand

Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for the…